China Sxt Pharmaceuticals, Inc. operates as a holding company, which engages in the research, development, manufacture, marketing, and sales of traditional Chinese medicine pieces (TCMP). The company is headquartered in Taizhou, Jiangsu and currently employs 75 full-time employees. The company went IPO on 2019-01-04. The firm sells different types of TCMP products, including Advanced TCMP and Regular TCMP. Advanced TCMP comprises of Directly-Oral-TCMP and After-Soaking-Oral TCMP. Regular TCMP is mainly for hospitals and drug stores for the treatment of various diseases or serving as dietary supplements. The firm sells its products under the brand Suxuantang.
China SXT Pharmaceuticals Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
China SXT Pharmaceuticals Inc 주요 수익원은 Advanced Traditional Chinese Medicine Pieces이며, 최신 수익 발표에서 수익은 946,015입니다. 지역별로는 China이 China SXT Pharmaceuticals Inc의 주요 시장이며, 수익은 1,928,497입니다.
China SXT Pharmaceuticals Inc은 수익성이 있나요?
no, 최신 재무제표에 따르면 China SXT Pharmaceuticals Inc의 순손실은 $0입니다.